Previous Article | Next Article ![]()
Antimicrobial Agents and Chemotherapy, March 2003, p. 1140-1142, Vol. 47, No. 3
0066-4804/03/$08.00+0 DOI: 10.1128/AAC.47.3.1140-1142.2003
Copyright © 2003, American Society for Microbiology. All Rights Reserved.
Department of Pathology, Hershey Medical Center, Hershey, Pennsylvania 17033,1 Department of Pathology, Case Western Reserve University, Cleveland, Ohio 441062
Received 24 July 2002/ Returned for modification 24 November 2002/ Accepted 16 December 2002
Conventional in vitro methods were used to determine the postantibiotic effects (PAEs), sub-MIC effects (SMEs), and postantibiotic sub-MIC effects (PA-SMEs) of garenoxacin for a range of organisms. The mean PAEs of garenoxacin for pneumococci, staphylococci, and enterococci were 0.3 to 2.2 h. For Escherichia coli and Pseudomonas aeruginosa, the PAEs were 0.9 to 1.6 h. The mean PA-SMEs (0.4 times the MIC) for pneumococci, staphylococci, and enterococci were 3.0 to >10 h, 1.8 to >10.7 h, and 5.8 h, respectively, while those for E. coli and P. aeruginosa were 7.6 and 4.4 h, respectively.
This article has been cited by other articles:
Copyright © 2009 by the American Society for Microbiology. For an alternate route to Journals.ASM.org, visit: http://intl-journals.asm.org | More Info»